378 related articles for article (PubMed ID: 18657585)
1. Recombinant Bacillus anthracis spore proteins enhance protection of mice primed with suboptimal amounts of protective antigen.
Cybulski RJ; Sanz P; McDaniel D; Darnell S; Bull RL; O'Brien AD
Vaccine; 2008 Sep; 26(38):4927-39. PubMed ID: 18657585
[TBL] [Abstract][Full Text] [Related]
2. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
Welkos S; Little S; Friedlander A; Fritz D; Fellows P
Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
[TBL] [Abstract][Full Text] [Related]
3. A Bivalent Protein r-PAbxpB Comprising PA Domain IV and Exosporium Protein BxpB Confers Protection Against
Majumder S; Das S; Somani VK; Makam SS; Kingston JJ; Bhatnagar R
Front Immunol; 2019; 10():498. PubMed ID: 30941133
[TBL] [Abstract][Full Text] [Related]
4. Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen.
Brahmbhatt TN; Darnell SC; Carvalho HM; Sanz P; Kang TJ; Bull RL; Rasmussen SB; Cross AS; O'Brien AD
Infect Immun; 2007 Nov; 75(11):5240-7. PubMed ID: 17785478
[TBL] [Abstract][Full Text] [Related]
5. Recombinant GroEL enhances protective antigen-mediated protection against Bacillus anthracis spore challenge.
Sinha K; Bhatnagar R
Med Microbiol Immunol; 2013 Apr; 202(2):153-65. PubMed ID: 23263010
[TBL] [Abstract][Full Text] [Related]
6. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
[TBL] [Abstract][Full Text] [Related]
7. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
[TBL] [Abstract][Full Text] [Related]
8. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions.
Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL
Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.
Gauthier YP; Tournier JN; Paucod JC; Corre JP; Mock M; Goossens PL; Vidal DR
Infect Immun; 2009 Mar; 77(3):1197-207. PubMed ID: 19114543
[TBL] [Abstract][Full Text] [Related]
10. Development of ELISA based on Bacillus anthracis capsule biosynthesis protein CapA for naturally acquired antibodies against anthrax.
Zorigt T; Furuta Y; Simbotwe M; Ochi A; Tsujinouchi M; Shawa M; Shimizu T; Isoda N; Enkhtuya J; Higashi H
PLoS One; 2021; 16(10):e0258317. PubMed ID: 34634075
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a multi-component anthrax vaccine designed to target the initial stages of infection as well as toxaemia.
Cote CK; Kaatz L; Reinhardt J; Bozue J; Tobery SA; Bassett AD; Sanz P; Darnell SC; Alem F; O'Brien AD; Welkos SL
J Med Microbiol; 2012 Oct; 61(Pt 10):1380-1392. PubMed ID: 22767539
[TBL] [Abstract][Full Text] [Related]
12. Protection of farm goats by combinations of recombinant peptides and formalin inactivated spores from a lethal Bacillus anthracis challenge under field conditions.
Koehler SM; Buyuk F; Celebi O; Demiraslan H; Doganay M; Sahin M; Moehring J; Ndumnego OC; Otlu S; van Heerden H; Beyer W
BMC Vet Res; 2017 Jul; 13(1):220. PubMed ID: 28701192
[TBL] [Abstract][Full Text] [Related]
13. Analysis of a novel spore antigen in Bacillus anthracis that contributes to spore opsonization.
Cote CK; Bozue J; Moody KL; DiMezzo TL; Chapman CE; Welkos SL
Microbiology (Reading); 2008 Feb; 154(Pt 2):619-632. PubMed ID: 18227265
[TBL] [Abstract][Full Text] [Related]
14. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
[TBL] [Abstract][Full Text] [Related]
15. Murine macrophages kill the vegetative form of Bacillus anthracis.
Kang TJ; Fenton MJ; Weiner MA; Hibbs S; Basu S; Baillie L; Cross AS
Infect Immun; 2005 Nov; 73(11):7495-501. PubMed ID: 16239551
[TBL] [Abstract][Full Text] [Related]
16. Immunization of mice with formalin-inactivated spores from avirulent Bacillus cereus strains provides significant protection from challenge with Bacillus anthracis Ames.
Vergis JM; Cote CK; Bozue J; Alem F; Ventura CL; Welkos SL; O'Brien AD
Clin Vaccine Immunol; 2013 Jan; 20(1):56-65. PubMed ID: 23114705
[TBL] [Abstract][Full Text] [Related]
17. A bivalent protein r-PB, comprising PA and BclA immunodominant regions for comprehensive protection against Bacillus anthracis.
Majumder S; Das S; Somani V; Makam SS; Joseph KJ; Bhatnagar R
Sci Rep; 2018 May; 8(1):7242. PubMed ID: 29740033
[TBL] [Abstract][Full Text] [Related]
18. Killed but metabolically active Bacillus anthracis vaccines induce broad and protective immunity against anthrax.
Skoble J; Beaber JW; Gao Y; Lovchik JA; Sower LE; Liu W; Luckett W; Peterson JW; Calendar R; Portnoy DA; Lyons CR; Dubensky TW
Infect Immun; 2009 Apr; 77(4):1649-63. PubMed ID: 19168734
[TBL] [Abstract][Full Text] [Related]
19. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components.
Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A
Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of the immunologic response induced by the Sterne 34F2 live spore Bacillus anthracis vaccine in a ruminant model.
Ndumnego OC; Köhler SM; Crafford J; van Heerden H; Beyer W
Vet Immunol Immunopathol; 2016 Oct; 178():14-21. PubMed ID: 27496738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
